ByHeart
ByHeart is an infant nutrition company. Its flagship product is a Whole Nutrition Infant Formula using organic, grass-fed whole milk.
Secondary Market Price
How ByHeart Measures Up
To help you manage your ByHeart equity, Prospect has run the company through our machine learning model.
Prospect Rating
--
This rating reflects our belief in this company's potential to grow to that many times its current value in 4 years. For an employee with stock, this rating suggests a potential return on equity, but it also comes with some risk.
Exit Risk
--
Our rating is a reflection of the likelihood of this company achieving a liquidity event for its employees based on the quality of investors, funding stage, founders, and more.
Funding Stage
Series D
A company’s funding stage reflects how established it is, how quickly it is scaling, and the average impact an employee may have when joining.
Secondary Market Price Chart
Create a free account to unlock real-time secondary market prices and future projections of ByHeart's value.
Sign up to Unlock the Latest DataData will be available soon.
Sign up to receive notifications when it is available.
Prospect Projected Future ByHeart Prices
Prospect’s machine learning model has been trained on the same data top-tier investors use to project the likely range of outcomes for ByHeart's equity. Create a free account to view 10th-90th percentile projections over 2, 4, and 6 years.
Powerful tools to earn more from your equity
Company Description
ByHeart is an infant nutrition company that researches, develops, manufactures, and markets its own infant formula. Founded in 2016 by Ron Belldegrun and Mia Funt, the New York-based company launched its Whole Nutrition Infant Formula in March 2022, becoming the first new U.S. infant formula manufacturer in 15 years. The company operates its own manufacturing facilities and uses organic, grass-fed whole milk in its formula. It is the first U.S. formula company to add alpha-lac and lactoferrin, two abundant proteins found in breast milk, and has received the Clean Label Project’s Purity Award after testing for 700 contaminants.
Looking forward, ByHeart is expanding its retail presence, including a recent launch at Sam's Club, and is involved in industry advocacy through government initiatives like "Operation Stork Speed" to modernize formula standards. The company also offers parent support services, such as a 24/7 hotline. In June 2024, ByHeart closed a $95 million Series C funding round, increasing its total funding to over $250 million to support continued growth and innovation.
- D1 Capital Partners
- Bellco Capital
- Polaris Partners
- Two River
- OCV Partners
- AF Ventures
- Red Sea Ventures
- Gaingels
- Co-Founder, Ron Belldegrun
- Co-Founder, Mia Funt
Peer Group Comparison
Vs Peer Group of >$4B Startups
Frequently Asked Questions
Joining Anduril as an employee is another way to acquire equity, typically through stock options included in compensation packages.
Is ByHeart worth joining?
Deciding whether to join a company like ByHeart depends on your personal career goals and financial situation. Tools like Prospect can help you analyze the value of an equity offer to make a more informed decision.
What should I do with my ByHeart stock?
Managing private company stock involves complex tax and financial planning that is unique to your personal situation. Platforms like Prospect offer customized strategies for exercising options and selling shares to help you maximize your potential returns.
Can you sell ByHeart stock?
Selling stock in a private company like ByHeart is typically possible during specific liquidity events, such as a tender offer or a secondary sale. Resources like Prospect provide tools to help you navigate these opportunities and decide on the optimal selling strategy.
How can I find the value of my ByHeart stock?
Valuing stock in a private company can be challenging as it doesn't trade on a public market. You can use platforms like Prospect, which leverage predictive models and proprietary data to help you forecast your equity's potential value.
What is ByHeart's equity worth?
The precise worth of private equity like ByHeart's fluctuates and is not publicly available. To understand its potential value, you can use specialized tools like Prospect that project a likely range of outcomes based on market data and company performance metrics.
What is ByHeart's stock ticker symbol?
As a private, pre-IPO company, ByHeart does not have a stock ticker symbol. Ticker symbols are only assigned to companies when they become publicly traded on a stock exchange.
Can I buy or sell ByHeart stock?
Selling your ByHeart stock is typically limited to company-approved liquidity events, while buying shares is usually restricted to accredited investors during funding rounds or employees receiving equity. Tools like Prospect are designed to help employees manage the equity they already hold.
What is the criteria to buy or invest in ByHeart stock?
The specific criteria to invest in a private company like ByHeart are not publicly disclosed and are set by the company itself. Investment opportunities are generally limited to institutional investors, accredited investors during specific funding rounds, or employees receiving equity compensation.
